Logo image of INDP

INDAPTUS THERAPEUTICS INC (INDP) Stock Overview

NASDAQ:INDP - US45339J1051 - Common Stock

3.303 USD
-1.31 (-28.35%)
Last: 9/5/2025, 8:22:40 PM
3.7 USD
+0.4 (+12.02%)
After Hours: 9/5/2025, 8:22:40 PM

INDP Key Statistics, Chart & Performance

Key Statistics
52 Week High58.24
52 Week Low3.21
Market Cap3.67M
Shares1.11M
Float890.00K
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-29.01
PEN/A
Fwd PEN/A
Earnings (Next)N/A N/A
IPO09-07 2012-09-07
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology


INDP short term performance overview.The bars show the price performance of INDP in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -20 -40 -60 -80

INDP long term performance overview.The bars show the price performance of INDP in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of INDP is 3.303 USD. In the past month the price decreased by -50.99%. In the past year, price decreased by -91.75%.

INDAPTUS THERAPEUTICS INC / INDP Daily stock chart

INDP Competitors/Peers

The largest stocks on the US markets in the "Biotechnology" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABBV ABBVIE INC 20.07 375.50B
AMGN AMGEN INC 13.01 152.70B
GILD GILEAD SCIENCES INC 14.86 142.76B
VRTX VERTEX PHARMACEUTICALS INC 23.38 101.56B
REGN REGENERON PHARMACEUTICALS 12.56 60.77B
ALNY ALNYLAM PHARMACEUTICALS INC N/A 59.25B
ARGX ARGENX SE - ADR 80.99 45.95B
ONC BEONE MEDICINES LTD-ADR 6.89 40.63B
INSM INSMED INC N/A 30.67B
BNTX BIONTECH SE-ADR N/A 27.03B
NTRA NATERA INC N/A 23.06B
BIIB BIOGEN INC 8.79 20.62B

About INDP

Company Profile

INDP logo image Indaptus Therapeutics, Inc. is a pre-clinical biotechnology company. The company is headquartered in New York City, New York and currently employs 7 full-time employees. The company went IPO on 2012-09-07. The Company’s approach is based on the hypothesis that activation of both innate and adaptive immune cells and pathways and associated anti-tumor and anti-viral immune responses will require a multi-targeted package of immune system-activating signals that can be administered safely intravenously (i.v.). Its technology is composed of single strains of attenuated and killed, non-pathogenic, Gram-negative bacteria producing a multiple Toll-like receptor (TLR), Nucleotide oligomerization domain (NOD)-like receptor (NLR) and Stimulator of interferon genes (STING) agonist Decoy platform. The firm's lead clinical candidate is Decoy20. Its Decoy product candidates have also produced significant single agent activity against chronic hepatitis B virus (HBV) and chronic human immunodeficiency virus (HIV) infections in pre-clinical models.

Company Info

INDAPTUS THERAPEUTICS INC

3 Columbus Circle, 15th Floor

New York City NEW YORK US

CEO: Jeffrey A. Meckler

Employees: 7

INDP Company Website

INDP Investor Relations

Phone: 16464272727

INDAPTUS THERAPEUTICS INC / INDP FAQ

What is the stock price of INDAPTUS THERAPEUTICS INC today?

The current stock price of INDP is 3.303 USD. The price decreased by -28.35% in the last trading session.


What is the ticker symbol for INDAPTUS THERAPEUTICS INC stock?

The exchange symbol of INDAPTUS THERAPEUTICS INC is INDP and it is listed on the Nasdaq exchange.


On which exchange is INDP stock listed?

INDP stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for INDAPTUS THERAPEUTICS INC stock?

7 analysts have analysed INDP and the average price target is 184.11 USD. This implies a price increase of 5474.02% is expected in the next year compared to the current price of 3.303. Check the INDAPTUS THERAPEUTICS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is INDAPTUS THERAPEUTICS INC worth?

INDAPTUS THERAPEUTICS INC (INDP) has a market capitalization of 3.67M USD. This makes INDP a Nano Cap stock.


How many employees does INDAPTUS THERAPEUTICS INC have?

INDAPTUS THERAPEUTICS INC (INDP) currently has 7 employees.


Should I buy INDAPTUS THERAPEUTICS INC (INDP) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does INDAPTUS THERAPEUTICS INC (INDP) stock pay dividends?

INDP does not pay a dividend.


What is the Price/Earnings (PE) ratio of INDAPTUS THERAPEUTICS INC (INDP)?

INDAPTUS THERAPEUTICS INC (INDP) does not have a PE ratio as the earnings reported over the last twelve months were negative (-29.01).


What is the Short Interest ratio of INDAPTUS THERAPEUTICS INC (INDP) stock?

The outstanding short interest for INDAPTUS THERAPEUTICS INC (INDP) is 2.1% of its float. Check the ownership tab for more information on the INDP short interest.


INDP Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

INDP Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to INDP. The financial health of INDP is average, but there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

INDP Financial Highlights

Over the last trailing twelve months INDP reported a non-GAAP Earnings per Share(EPS) of -29.01. The EPS decreased by -1451.34% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -291%
ROE -562.48%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%-1834.04%
Sales Q2Q%N/A
EPS 1Y (TTM)-1451.34%
Revenue 1Y (TTM)N/A

INDP Forecast & Estimates

7 analysts have analysed INDP and the average price target is 184.11 USD. This implies a price increase of 5474.02% is expected in the next year compared to the current price of 3.303.


Analysts
Analysts82.86
Price Target184.11 (5474.02%)
EPS Next Y-128.21%
Revenue Next YearN/A

INDP Ownership

Ownership
Inst Owners6.7%
Ins Owners16%
Short Float %2.1%
Short Ratio0